| Description | Ralpancizumab, a selective PCSK9 inhibitor, shows potential for use in hemorrhagic stroke [1]. |
| molecular weight | N/A |
| CAS | 1407495-04-8 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |
| Description | Ralpancizumab, a selective PCSK9 inhibitor, shows potential for use in hemorrhagic stroke [1]. |
| molecular weight | N/A |
| CAS | 1407495-04-8 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |